TITLE

Impact of gender on renal disease: the role of renin angiotensin system

AUTHOR(S)
Kang, Amrit K.; Miller, Judith A.
PUB. DATE
February 2003
SOURCE
Clinical & Investigative Medicine;Feb2003, Vol. 26 Issue 1, p38
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Focuses on studies examining the sex differences in renal function, blood pressure and the renin angiotensin system. Incidence of cardiovascular disease in premenopausal women; Impact of gender on blood pressure; Gender distribution of end-stage renal disease.
ACCESSION #
9321820

 

Related Articles

  • The Authors Reply:. Sarafidis, Pantelis A; Ruilope, Luis M // Kidney International;Oct2014, Vol. 86 Issue 4, p855 

    A response from the author of the article "Aggressive blood pressure reduction and reninangiotensin system blockade in chronic kidney disease: time for reevaluation?," in the 2014 issue is presented.

  • Lower blood pressure target in nondiabetic proteinuric chronic kidney disease is not justified. McCormick, Brendan B; Hiremath, Swapnil; Ruzicka, Marcel // Kidney International;Oct2014, Vol. 86 Issue 4, p855 

    A letter to the editor is presented in response to the article "Aggressive blood pressure reduction and reninangiotensin system blockade in chronic kidney disease: time for reevaluation?," by P. A. Sarafidis and L. M. Ruilope.

  • Urinary Angiotensinogen and Renin Excretion are Associated with Chronic Kidney Disease. Juretzko, Annett; Steinbach, Antje; Hannemann, Anke; Endlich, Karlhans; Endlich, Nicole; Friedrich, Nele; Lendeckel, Uwe; Stracke, Sylvia; Rettig, Rainer // Kidney & Blood Pressure Research;May2017, Vol. 42 Issue 1, p145 

    Background/Aims: Several studies sought to identify new biomarkers for chronic kidney disease (CKD). As the renal renin-angiotensin system is activated in CKD, urinary angiotensinogen or renin excretion may be suitable candidates. We tested whether urinary angiotensinogen or renin excretion is...

  • The OSCAR for cardiovascular disease prevention in chronic kidney disease goes to blood pressure control. Briasoulis, Alexandros; Bakris, George L // Kidney International;Jan2013, Vol. 83 Issue 1, p20 

    Nephropathy progression is slowed and cardiovascular events reduced in patients with stage 3 or higher chronic kidney disease when blood pressure is controlled using combinations of renin-angiotensin system (RAS) blockers with dihydropyridine calcium channel blockers or diuretics. We discuss a...

  • The renin-angiotensin-aldosterone system in terminal renal failure. Weidmann, Peter; Maxwell, Morton H. // Kidney International Supplement;Sep1975, Issue 5, p219 

    Focuses on the importance of the renin-angiotensin-aldosterone system in the regulation of blood pressure and sodium and potassium metabolism. Details on the function of the system in patients with terminal renal failure; Role of the system and other factors in the control of aldosterone...

  • Evidence for renoprotection by blockade of the renin–angiotensin–aldosterone system in hypertension and diabetes. Karalliedde, J.; Viberti, G. // Journal of Human Hypertension;Apr2006, Vol. 20 Issue 4, p239 

    The incidence of end-stage renal disease (ESRD) is rising worldwide, accompanied by corresponding increases in the risk of morbidity and mortality. Underlying this trend are increasing rates of hypertension and diabetes mellitus, the two most common causes of ESRD. In addition to the adverse...

  • Aliskiren suppresses the renin-angiotensin-aldosterone system and reduces blood pressure and albuminuria in elderly chronic kidney disease patients with hypertension. Morishita, Yoshiyuki; Yasui, Toshihiro; Numata, Akihiko; Onishi, Akira; Ishibashi, Kenichi; Kusano, Eiji // International Journal of Nephrology & Renovascular Disease;2012 Part 2, Vol. 5, p125 

    We investigated the effects of aliskiren in terms of its inhibition of the renin-angiotensin-aldosterone system (RAAS) as well as that on blood pressure (BP), and renal and cardiac protection in elderly chronic kidney disease (CKD) patients with hypertension. Methods: Nineteen elderly CKD...

  • The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease. Remuzzi, Giuseppe; Perico, Norberto; Macia, Manuel; Ruggenenti, Piero // Kidney International Supplement;Dec2005, Issue 99, pS57 

    The renin-angiotensin-aldosterone system (RAAS) is a well known regulator of blood pressure (BP) and determinant of target-organ damage. It controls fluid and electrolyte balance through coordinated effects on the heart, blood vessels, and Kidneys. Angiotensin II (AII) is the main effector of...

  • Diabetic nephropathy -- Epidemiology in Asia and the current state of treatment. Ritz, E.; Zeng, X. // Indian Journal of Nephrology;Apr-Jun2011, Vol. 21 Issue 2, p75 

    The article discusses the epidemiology of diabetic nephropathy in Asia and the state of treatment of April 2011. Diabetes is identified by the World Health Organization as a major health problem in Asia and prevention of diabetes has reportedly become a high priority of health policies. The main...

  • Treatment of Hypertension With Renin-Angiotensin System Inhibitors and Renal Dysfunction: A Systematic Review and Meta-Analysis. Daien, Vincent; Duny, Yohan; Ribstein, Jean; du Cailar, Guilhem; Mimran, Albert; Villain, Max; Daures, Jean P.; Fesler, Pierre // American Journal of Hypertension;Jan2012, Vol. 25 Issue 1, p126 

    BackgroundTo determine whether inhibitors of the renin-angiotensin system (RAS) reduce the incidence of renal dysfunction when compared to other antihypertensive treatments in patients with essential hypertension and no pre-existent renal disease.MethodsThe search strategy used the Cochrane...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics